1. a INSERM, CIC-EC, CIE6, Nancy, France;
2. b Department of Clinical Epidemiology and Evaluation Department, CHU Nancy, Vandoeuvre-lès-Nancy, France;
3. c Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy, France;
4. d Quality of Life in Oncology Platform, France;
5. e Biostatistic and Epidemiological Unit, Centre Georges-François Leclerc, University of Burgundy, Dijon, France;
6. f Department of Epidemiology and Biostatistics, Centre Paul Strauss, University of Strasbourg, Strasbourg, France;
7. g Department of Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France